NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1891721106 M.D
Verify on CMS → Mubina Gaffar, M.D
Pulmonary Disease Physician in Newport Beach, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 703 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
21.1/100
▼ 62 pts below national avg 83.5 · Below average
Industry payments
$324.71
6 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mubina Gaffar, M.D reported a CMS MIPS final score of 21.1/100 - below the 83.5 national average - and filed 3,716 Medicare Part D claims in 2024.
- 21.1/100
- MIPS score · -62 vs avg
- 4K
- Part D claims, 2024
- 49%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mubina Gaffar, M.D
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1891721106), first enumerated 06/26/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,716 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 21.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$324.71 in reported industry payments (6 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Mubina Gaffar, M.D's individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1891721106 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1891721106
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- MIPS-LOW 21.1/100
- RX-MID 3,716
- BOOK-LIGHT 905 in California
- PHOTO-FINISH Martin Baskin · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Alain Eid · lowest
Alain Eid
20.8 MIPS pts
- Gaffar · this pr…
Gaffar · this provider
21.1 MIPS pts
- Riaz Chaudhry · …
Riaz Chaudhry
21.2 MIPS pts
- Martin Baskin · …
Martin Baskin
21.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mubina Gaffar, M.D's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
21 ≥ 3rd percentile 3% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mubina Gaffar, M.D sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mubina Gaffar, M.D writes more Part D claims than 89% of them and scores higher on MIPS quality than 4% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Mubina Gaffar, M.D. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mubina Gaffar, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mubina Gaffar, M.D?
Below national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
3,716 148% vs specialty avg
MIPS final score
21.1/100 62.4 pts vs avg
Specialty distribution in California
How Pulmonary Disease Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Mubina Gaffar, M.D's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 21.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1891721106 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D |
| Gender | Female |
| NPI Issued | 06/26/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
21.0651
Final Score
Measured-score avg: 83.5
0
Quality
70.217
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mubina Gaffar, M.D. Source: openpaymentsdata.cms.gov.
Total received
$325
Largest payer
Pulmonx Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Mubina Gaffar, M.D. To verify Mubina Gaffar, M.D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Mubina Gaffar, M.D - brand share 51.0%
Pulmonary Disease Physician average
51% brand-name claims vs 49% generic, on 3,716 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,716
Total Claims
$2.2M
Total Drug Cost
703
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,132.367
- Total Day Supply
- 168,483
- Brand vs Generic
- 51% brand / 49% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $80K
- Antibiotic Claims
- 301
Patient Demographics
- Average Patient Age
- 77.6 years
- Avg HCC Risk Score
- 1.84
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 22, 65-74: 225, 75-84: 325, 85+: 131
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mubina Gaffar, M.D prescribes most
Top Medicare Part D drugs by claim count, 2024
- Montelukast Sodium
Montelukast Sodium
482 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
443 claims
- Trelegy Ellipta
Trelegy Ellipta
403 claims
- Breo Ellipta
Breo Ellipta
386 claims
- Fluticasone-Salmet… 188
Fluticasone-Salmeterol
188 claims
- Methylprednisolone 160
Methylprednisolone
160 claims
- Wixela Inhub 144
Wixela Inhub
144 claims
- Ipratropium Bromide 140
Ipratropium Bromide
140 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 482 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 443 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 403 |
| Breo Ellipta Fluticasone/Vilanterol | 386 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 188 |
| Methylprednisolone | 160 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 144 |
| Ipratropium Bromide | 140 |
| Azithromycin | 127 |
| Prednisone | 109 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Mubina Gaffar, M.D fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Mubina Gaffar, M.D's 3,716 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gaffar, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (21.1 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Gaffar.
One of 905 Pulmonary Disease Physician providers enrolled in California, 5 are shown here.
Dr. Manoochehr Abadian Sharifabad
M.D.
Fountain Valley, CA
Dr. Mohamad Abdelfattah
MD
Fullerton, CA
Zainab Abdulsada
MBCHB
Sacramento, CA
Dr. Ayham Aboeed
M.D.
Bakersfield, CA
Dr. Babak Abrishami
D.O.
Los Angeles, CA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mubina Gaffar, M.D's specialty? ▼
Mubina Gaffar, M.D specializes in Pulmonary Disease Physician and practices in Newport Beach, California. Credentials: M.D.
How much does Mubina Gaffar, M.D prescribe under Medicare Part D? ▼
In 2024, Mubina Gaffar, M.D wrote 3,716 Medicare Part D claims totaling $2.2M in drug costs for 703 beneficiaries.
What is Mubina Gaffar, M.D's Medicare quality score? ▼
Mubina Gaffar, M.D has a CMS MIPS Final Score of 21.1/100 (Quality: 0, Cost: 70.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mubina Gaffar, M.D located? ▼
Mubina Gaffar, M.D is located at 320 SUPERIOR AVE STE 270, Newport Beach, CA, 92663. Phone: (949) 287-6182.
What is Mubina Gaffar, M.D's NPI number? ▼
Mubina Gaffar, M.D's National Provider Identifier (NPI) is 1891721106, issued on 06/26/2006.
Does Mubina Gaffar, M.D prescribe more brand-name or generic drugs? ▼
Mubina Gaffar, M.D's prescribing is 51% brand-name and 49% generic drugs by claim count, with $2.1M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Mubina Gaffar, M.D prescribe most often? ▼
Based on 2024 Medicare Part D data, Mubina Gaffar, M.D's most frequently prescribed drugs include Montelukast Sodium, Albuterol Sulfate Hfa, Trelegy Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mubina Gaffar, M.D accept Medicare? ▼
Mubina Gaffar, M.D appears in CMS Medicare data with 3,716 Part D claims and 703 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mubina Gaffar, M.D's credentials? ▼
Mubina Gaffar, M.D's NPI is 1891721106 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.